Evidence map›Paper›PMID 29444433›Full record

ArticleCell reports2018

MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation.

Wenqing Zhou, Arpita S Pal, Alan Yi-Hui Hsu, Theodore Gurol, Xiaoguang Zhu, Sara E Wirbisky-Hershberger, Jennifer L Freeman, Andrea L Kasinski, Qing Deng

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. RABEP1 amplifies front signaling in neutrophil migration.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wenqing ZhouDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Arpita S PalDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Alan Yi-Hui HsuDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Theodore GurolDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Xiaoguang ZhuDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Sara E Wirbisky-HershbergerSchool of Health Sciences, Purdue University, West Lafayette, IN 47907, USA.
Jennifer L FreemanSchool of Health Sciences, Purdue University, West Lafayette, IN 47907, USA; Purdue University Center for Cancer Research, West Lafayette, IN 47907, USA.
Andrea L KasinskiDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA; Purdue University Center for Cancer Research, West Lafayette, IN 47907, USA.
Qing DengDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA; Purdue University Center for Cancer Research, West Lafayette, IN 47907, USA; Purdue Institute for Inflammation, Immunology, and Infectious Disease, West Lafayette, IN 47907, USA. Electronic address: deng67@purdue.edu.
Purdue University West Lafayette · USCenter for Cancer Research · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Role of microRNAs in neutrophil migrationR35GM119787 · NIGMS · PURDUE UNIVERSITY · PI Qing Deng · 2016 to 2026
$4.9M
Enhancing miRNA Therapeutics through Vehicle Free DeliveryR01CA205420 · NCI · PURDUE UNIVERSITY · PI Andrea L Kasinski · 2017 to 2026
$2.9M
Identification and Therapeutic Application of miRNA-Drivers in Lung CancerR00CA178091 · NCI · PURDUE UNIVERSITY · PI KASINSKI, ANDREA L · 2014 to 2016
$734k
NCI NIH HHS P30 CA023168NCI NIH HHS R00 CA178091NCI NIH HHS R01 CA205420NIGMS NIH HHS R35 GM119787
6 · The paper itself

Abstract

MicroRNA-223 is known as a myeloid-enriched anti-inflammatory microRNA that is dysregulated in numerous inflammatory conditions. Here, we report that neutrophilic inflammation (wound response) is augmented in miR-223-deficient zebrafish, due primarily to elevated activation of the canonical nuclear factor κB (NF-κB) pathway. NF-κB over-activation is restricted to the basal layer of the surface epithelium, although miR-223 is detected throughout the epithelium and in phagocytes. Not only phagocytes but also epithelial cells are involved in miR-223-mediated regulation of neutrophils' wound response and NF-κB activation. Cul1a/b, Traf6, and Tab1 are identified as direct targets of miR-223, and their levels rise in injured epithelium lacking miR-223. In addition, miR-223 is expressed in cultured human bronchial epithelial cells, where it also downregulates NF-κB signaling. Together, this direct connection between miR-223 and the canonical NF-κB pathway provides a mechanistic understanding of the multifaceted role of miR-223 and highlights the relevance of epithelial cells in dampening neutrophil activation.

Indexed as

Signal TransductionAnimal FinsAnimalsBase SequenceBronchiEmbryo, NonmammalianEpithelial CellsHEK293 CellsHumansInflammationKeratinocytesMicroRNAsNeutrophilsNF-kappa BPhagocytesRegenerationmicroRNA-223, zebrafishMicroRNAsMIR223, humanNF-kappa BZebrafish ProteinsepitheliuminflammationmicroRNAmiR-223neutrophilsNF-κBzebrafish

Identifiers

PMID29444433
PMCPMC5839657
OpenAlexW2785377476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.